Profile picture

Doctor Hideki Usuda

(Japan)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

The Apolipoprotein A2/Apolipoprotein C3 ratio predicts future cardiovascular events after percutaneous coronary intervention in patients receiving LDL-cholesterol-lowering therapy
Presentation
The Apolipoprotein A2/Apolipoprotein C3 ratio predicts future cardiovascular events after percutaneous coronary intervention in patients receiving LDL-cholesterol-lowering therapy
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources